Determination of a Statistically Valid Neutralization Titer in Plasma That Confers Protection against Simian-Human Immunodeficiency Virus Challenge following Passive Transfer of High-Titered Neutralizing Antibodies

Documenti analoghi

• Early Control of Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys Usually Results in Long-Lasting Asymptomatic Clinical Outcomes
  di: Igarashi, Tatsuhiko, et al.
  Pubblicazione: (2003)
• Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus
  di: Endo, Yasuyuki, et al.
  Pubblicazione: (2000)
• Induction of Disease by a Molecularly Cloned Highly Pathogenic Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimera Is Multigenic
  di: Sadjadpour, Reza, et al.
  Pubblicazione: (2004)
• CD8(+) and CD20(+) Lymphocytes Cooperate To Control Acute Simian Immunodeficiency Virus/Human Immunodeficiency Virus Chimeric Virus Infections in Rhesus Monkeys: Modulation by Major Histocompatibility Complex Genotype
  di: Mao, Hanwen, et al.
  Pubblicazione: (2005)
• Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus
  di: Igarashi, Tatsuhiko, et al.
  Pubblicazione: (1999)